Title: Ching-Cheng Wang: Innovator in Central Nervous System Treatments
Introduction
Ching-Cheng Wang is a notable inventor based in China, recognized for his contributions to the field of pharmaceutical compositions aimed at treating central nervous system disorders. His innovative work focuses on the development of compositions that utilize unique compounds for therapeutic purposes.
Latest Patents
Ching-Cheng Wang has recently developed two significant patents. The first patent is titled "Compositions Containing Benzoate Compound And Tannic Acid For Treating Central Nervous System Disorders." This patent describes pharmaceutical and nutraceutical compositions that include a benzoate compound and tannic acid as an excipient, aimed at treating various central nervous system disorders. The second patent is "Co-Crystals Of Lithium Benzoate And Uses Thereof." This patent provides co-crystals of lithium benzoate and a co-former compound, detailing methods for preparing these co-crystals and their applications in treating neuropsychiatric disorders such as schizophrenia and bipolar disorders.
Career Highlights
Ching-Cheng Wang is associated with Syneurx International Corp., where he continues to advance his research and development efforts. His work is pivotal in the exploration of new therapeutic avenues for complex neurological conditions.
Collaborations
Ching-Cheng Wang collaborates with Tien-Lan Hsieh, who is also a key figure in his research endeavors. Their partnership enhances the innovative potential of their projects and contributes to the advancement of treatments for central nervous system disorders.
Conclusion
Ching-Cheng Wang's innovative contributions to the field of pharmaceuticals, particularly in the treatment of central nervous system disorders, highlight his role as a significant inventor. His ongoing research and collaborations promise to lead to impactful advancements in medical science.